Vidadi Yusibov Selected Research

Vidadi Yusibov Research Topics

Disease

18	Human Influenza (Influenza) 01/2019 - 01/2007
13	Infections 01/2020 - 01/2008
7	Influenza in Birds (Avian Flu) 01/2019 - 02/2009
7	Malaria 01/2018 - 01/2011
5	Communicable Diseases (Infectious Diseases) 01/2016 - 01/2013
5	Anthrax 01/2016 - 03/2005
3	Virus Diseases (Viral Diseases) 01/2020 - 06/2008
3	Neoplasms (Cancer) 01/2016 - 04/2007
2	Rabies (Hydrophobia) 01/2022 - 03/2011
1	Edema (Dropsy) 01/2022
1	Ebola Hemorrhagic Fever 01/2020
1	Fever (Fevers) 12/2019
1	Viremia 12/2019
1	Encephalitis (Encephalitis, Rasmussen) 12/2019
1	Lymphopenia (Lymphocytopenia) 12/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Yellow Fever 01/2018
1	Gaucher Disease (Gaucher's Disease) 10/2017
1	Respiratory Syncytial Virus Infections 02/2016
1	Noncommunicable Diseases 12/2012
1	Hemolysis 05/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2011
1	Hepatitis B 03/2011
1	Dental Caries (Decay, Dental) 03/2011
1	Newcastle Disease 03/2011
1	Plague (Bubonic Plague) 05/2009
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 05/2009
1	Zoonoses 04/2009
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2007
1	Insulinoma 02/2007
1	Animal Diseases 01/2006
1	Tetanus 08/2005

Drug/Important Bio-Agent (IBA)

37	VaccinesIBA 12/2019 - 01/2006
20	AntigensIBA 01/2022 - 08/2005
12	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 01/2008
8	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2007
5	Subunit VaccinesIBA 01/2018 - 01/2008
5	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2015 - 06/2008
4	Monoclonal AntibodiesIBA 02/2016 - 03/2005
3	AntibodiesIBA 01/2018 - 02/2009
2	Antiviral Agents (Antivirals)IBA 10/2015 - 01/2011
2	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2015 - 01/2013
2	Silicon Dioxide (Silica)FDA LinkGeneric 05/2014 - 01/2013
2	bis(3',5')-cyclic diguanylic acidIBA 05/2014 - 07/2011
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 05/2014 - 07/2011
2	Immunoglobulin G (IgG)IBA 05/2012 - 04/2007
1	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Combined Antibody TherapeuticsIBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	EpitopesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	avian influenza A virus hemagglutininIBA 01/2019
1	SolutionsIBA 01/2019
1	Neutralizing AntibodiesIBA 01/2018
1	Plasmodium falciparum Pfs25 proteinIBA 11/2017
1	taliglucerase alfaIBA 10/2017
1	SuspensionsIBA 10/2017
1	Peptides (Polypeptides)IBA 02/2016
1	Antisense RNA (Anti-Sense RNA)IBA 11/2011
1	Green Fluorescent ProteinsIBA 11/2011
1	Zanamivir (Relenza)FDA Link 01/2011
1	Neuraminidase (Sialidase)IBA 01/2011
1	Biological ProductsIBA 01/2011
1	Biological Warfare AgentsIBA 05/2009
1	Carrier Proteins (Binding Protein)IBA 01/2008
1	Tyrosine (L-Tyrosine)FDA Link 02/2007
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2007
1	AutoantigensIBA 02/2007
1	GlucuronidaseIBA 08/2005

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2016
2	Injections 03/2011 - 04/2007
1	Immunotherapy 05/2009